Simona Corso

About Simona Corso

Simona Corso, With an exceptional h-index of 33 and a recent h-index of 27 (since 2020), a distinguished researcher at Università degli Studi di Torino, specializes in the field of cancer research.

His recent articles reflect a diverse array of research interests and contributions to the field:

Targeting SMAD3 Improves Response to Oxaliplatin in Esophageal Adenocarcinoma Models by Impeding DNA Repair

Targeting vulnerabilities of drug-tolerant persister cells in gastric cancer

Increased genomic instability and reshaping of tissue microenvironment underlie oncogenic properties of Arid1a mutations

Biological and targeting differences between the rare KRAS A146T and canonical KRAS mutants in gastric cancer models

Dalle cellule ai sistemi. Citologia–Istologia–Anatomia microscopica

CAF-released galectin 1 mediates non-cell-autonomous resistance to ceritinib in NSCLC.

Fatty acid synthase as a new therapeutic target for HER2-positive gastric cancer

BRCA2 Germline Mutations Identify Gastric Cancers Responsive to PARP Inhibitors

Simona Corso Information

University

Position

___

Citations(all)

5921

Citations(since 2020)

2011

Cited By

4652

hIndex(all)

33

hIndex(since 2020)

27

i10Index(all)

43

i10Index(since 2020)

41

Email

University Profile Page

Google Scholar

Simona Corso Skills & Research Interests

cancer research

Top articles of Simona Corso

Targeting SMAD3 Improves Response to Oxaliplatin in Esophageal Adenocarcinoma Models by Impeding DNA Repair

Clinical Cancer Research

2024/4/9

Targeting vulnerabilities of drug-tolerant persister cells in gastric cancer

Cancer Research

2024/3/22

Simona Corso
Simona Corso

H-Index: 27

Silvia Giordano
Silvia Giordano

H-Index: 28

Increased genomic instability and reshaping of tissue microenvironment underlie oncogenic properties of Arid1a mutations

Science Advances

2024/3/15

Biological and targeting differences between the rare KRAS A146T and canonical KRAS mutants in gastric cancer models

Gastric Cancer

2024/1/23

Dalle cellule ai sistemi. Citologia–Istologia–Anatomia microscopica

2024

CAF-released galectin 1 mediates non-cell-autonomous resistance to ceritinib in NSCLC.

2023/7/31

Silvia Giordano
Silvia Giordano

H-Index: 28

Simona Corso
Simona Corso

H-Index: 27

Fatty acid synthase as a new therapeutic target for HER2-positive gastric cancer

Cellular Oncology

2023/6

HER2 Copy Number and Resistance Mechanisms in Patients with HER2-positive Advanced Gastric Cancer Receiving Initial Trastuzumab-based Therapy in JACOB Trial

Clinical Cancer Research

2023/2/1

Identification of a subpopulation of patients with gastric cancer responsive to PARP inhibitors.

2023/2/1

The importance of being CAFs (in cancer resistance to targeted therapies)

2022/11/3

Silvia Giordano
Silvia Giordano

H-Index: 28

Simona Corso
Simona Corso

H-Index: 27

1206P HER2 copy number variation (CNV), HER2 expression and primary resistance mechanisms in patients (pts) with HER2-positive metastatic gastric or gastroesophageal junction …

Annals of Oncology

2022/9/1

hOA-DN30: a highly effective humanized single-arm MET antibody inducing remission of ‘MET-addicted’cancers

Journal of Experimental & Clinical Cancer Research

2022/3/29

A novel strategy for combination of clofarabine and pictilisib is synergistic in gastric cancer

Translational oncology

2022/1/1

Microsatellite instability in Gastric Cancer: Between lights and shadows

2021/4/1

Simona Corso
Simona Corso

H-Index: 27

Silvia Giordano
Silvia Giordano

H-Index: 28

Molecular Classification of Gastric Cancer: A New Perspective for Therapy and Prognosis?

Gastric Cancer: the 25-year R-Evolution

2021

Simona Corso
Simona Corso

H-Index: 27

Silvia Giordano
Silvia Giordano

H-Index: 28

Gastric cancer: the 25-year R-evolution

2021/10/15

2.1 The TCGA Molecular Classification

Gastric Cancer: the 25-year R-Evolution

2021/10/15

See List of Professors in Simona Corso University(Università degli Studi di Torino)